Approval · Notice of Compliance 11316 · 2010
CYSTADANE: Notice of Compliance 11316
Issued April 28, 2010
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 11316
- Date
- April 28, 2010
- Company
- Orphan Europe Sarl
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Anti-homocysteine agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CYSTADANE | 02238526 | Marketed |
Medicinal ingredients
- BETAINE 1 G per 1.7CC